An A2Aadenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models

Abstract
The pathophysiology of sepsis is due in part to early systemic inflammation. Here we describe molecular and cellular responses, as well as survival, in A2A adenosine receptor (AR) agonist treated and untreated animals during experimental sepsis.

This publication has 36 references indexed in Scilit: